Jens Wrammert

Title: The Innovative Contributions of Jens Wrammert

Introduction

Jens Wrammert is a notable inventor based in Decatur, GA (US), recognized for his significant contributions to the field of immunology. With a total of five patents to his name, Wrammert has made strides in developing antibodies that target influenza viruses, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Wrammert's latest patents include groundbreaking work on antibodies directed against influenza. These antibodies specifically bind to the hemagglutinin A (HA) of the influenza virus, providing a means for broad neutralization. His patents also disclose nucleic acids encoding these monoclonal antibodies, as well as vectors and host cells transformed with these nucleic acids. The compositions described in his patents include antibodies, antigen binding fragments, nucleic acids, vectors, and host cells. Furthermore, methods for using these antibodies and related components for the diagnosis and treatment of influenza virus infections are also provided.

Career Highlights

Throughout his career, Jens Wrammert has worked with prestigious institutions such as Emory University and the University of Chicago. His work has significantly impacted the understanding and treatment of influenza, positioning him as a key figure in the field of antibody research.

Collaborations

Wrammert has collaborated with esteemed colleagues, including Rafi Ahmed and Patrick C. Wilson. These partnerships have further enhanced his research and contributed to the advancement of immunological studies.

Conclusion

Jens Wrammert's innovative work in developing antibodies against influenza highlights his commitment to improving public health through scientific research. His contributions continue to influence the field and pave the way for future advancements in medical treatments.